Transmissible spongiform encephalopathy
| Prion diseases | |
|---|---|
| Other names | Transmissible spongiform encephalopathy (TSE) |
| Micrograph showing spongiform degeneration (vacuoles that appear as holes in tissue sections) in the cerebral cortex of a patient who had died of Creutzfeldt–Jakob disease. H&E stain, scale bar = 30 microns (0.03 mm). | |
| Specialty | Infectious diseases |
| Symptoms | Dementia, seizures, tremors, insomnia, psychosis, delirium, confusion |
| Usual onset | Months to decades |
| Types | Bovine spongiform encephalopathy, Fatal familial insomnia, Creutzfeldt-Jakob disease, kuru, Huntington's disease-like 1, scrapie, variably protease-sensitive prionopathy, chronic wasting disease, Gerstmann-Sträussler-Scheinker syndrome, feline spongiform encephalopathy, transmissible mink encephalopathy, exotic ungulate encephalopathy, camel spongiform encephalopathy, PrP systemic amyloidosis, Familial Alzheimer-like prion disease |
| Causes | Prion |
| Risk factors | Contact with infected fluids, ingestion of infected flesh, having one or two parents that have the disease (in case of fatal familial insomnia) |
| Diagnostic method | Currently there is no way to reliably detect prions except at post-mortem |
| Prevention | Varies |
| Treatment | Palliative care |
| Prognosis | Invariably fatal |
| Frequency | Rare |
Prion diseases, also known as transmissible spongiform encephalopathies (TSEs),[1] are a group of progressive, incurable, and invariably fatal conditions that are associated with the degeneration of the nervous system in many animals, including humans, cattle, and sheep. Strong evidence now supports the once unorthodox hypothesis that prion diseases are transmitted by abnormally shaped protein molecules known as prions.[2][3] Prions consist of a protein called the prion protein (PrP).[2] Misshapen PrP (often referred to as PrPSc) conveys its abnormal structure to naive PrP molecules by a crystallization-like seeding process. Because the abnormal proteins stick to each other, and because PrP is continuously produced by cells, PrPSc accumulates in the brain, harming neurons and eventually causing clinical disease.[2][4][3]
Prion diseases are marked by mental and physical deterioration that worsens over time.[5][6] A defining pathologic characteristic of prion diseases is the appearance of small vacuoles in the various parts of the central nervous system that create a sponge-like appearance when brain tissue obtained at autopsy is examined under a microscope.[2][3] Other changes in affected regions include the buildup of PrPSc, gliosis, and the loss of neurons.[7]
In non-human mammals, the prion diseases include scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle (popularly known as "mad cow disease") chronic wasting disease (CWD) in deer and elk, and others.[8] prion diseases of humans include Creutzfeldt–Jakob disease, Gerstmann–Sträussler–Scheinker syndrome, fatal familial insomnia, kuru, and variably protease-sensitive prionopathy.[6][9] Creutzfeldt-Jakob disease has been divided into four subtypes: sporadic (sCJD), hereditary/familial (fCJD), iatrogenic (iCJD) and variant (vCJD). These diseases form a spectrum of related conditions with overlapping signs and symptoms.
Prion diseases are unusual in that their aetiology may be genetic, infectious, or sporadic.[2] Genetic (inherited) prion diseases result from rare mutations in PRNP, the gene that codes for PrP (see Genetics, below). Unlike conventional infectious diseases, which are spread by agents with a DNA or RNA genome (such as viruses or bacteria), prion diseases are transmitted by prions, the active material of which is solely abnormal PrP. Infection can occur when the organism is exposed to prions through ingestion of infected foodstuffs or via iatrogenic means (such as treatment with biologic material that had been inadvertently contaminated with prions).[10] The variant form of Creutzfeldt–Jakob disease in humans is caused by exposure to BSE prions.[11][12][13] Whereas the naturally occurring transmission of prion diseases among nonhuman species is relatively common, prion transmission to humans is very rare; rather, the majority of human prion diseases are sporadic (idiopathic) in nature[14] (see Infectivity, below). Sporadic prion diseases occur in the absence of a mutation in PrP or a source of infection.
Although research has shown that the infectious capacity of prions is encoded in the conformation of PrPSc,[2][4] it is likely that auxilliary components contribute to their formation and/or infectivity. Purified PrPC appears to be unable to convert to the infectious PrPSc form in a protein misfolding cyclic amplification (PMCA) assay unless other components are added, such as a polyanion (usually RNA) and lipids. These other components, termed cofactors, may form part of the infectious prion, or they may serve as catalysts for the replication of a protein-only prion.[15] Considering that the cofactors can be produced by chemical synthesis instead of being sourced solely from infected cases (or any animal at all), it is fair to say that they do not form the infectious part of the prion. However, these catalysts (especially the polyanion) do have a tendency to be included in the prion aggregate, which makes seeding new aggregates easier in vitro.[16][17]
- ^ "Transmissible Spongiform Encephalopathies". National Institute of Neurological Disorders and Stroke. Retrieved 23 April 2023.
- ^ a b c d e f Prusiner, S. B. (10 November 1998). "Prions". Proceedings of the National Academy of Sciences of the United States of America. 95 (23): 13363–13383. Bibcode:1998PNAS...9513363P. doi:10.1073/pnas.95.23.13363. PMC 33918. PMID 9811807.
- ^ a b c Wadsworth JD, Collinge J (August 2010). "Molecular pathology of human prion disease". Acta Neuropathologica. 121 (1): 69–77. doi:10.1007/s00401-010-0735-5. PMC 3015177. PMID 20694796.
- ^ a b Aguzzi A, Calella AM (2009). "Prions: protein aggregation and infectious diseases". Physiology Reviews. 89 (4): 1105–1152. doi:10.1152/physrev.00006.2009. PMID 19789378.
- ^ Chesebro, Bruce (June 2003). "Introduction to the transmissible spongiform encephalopathies or prion diseases". British Medical Bulletin. 66 (1): 1–20. doi:10.1093/bmb/66.1.1. PMID 14522845.
- ^ a b Wadsworth JD, Collinge J (2007). "Update on human prion disease". Biochim Biophys Acta. 1772 (6): 598–609. doi:10.1016/j.bbadis.2007.02.010. PMID 17408929.
- ^ Ritchie DL, Smith C (2025). "Pathological spectrum of sporadic Creutzfeldt-Jakob disease". Pathology. 57 (2): 196–206. doi:10.1016/j.pathol.2024.09.005. PMID 39665904.
- ^ Imran M, Mahmood S (November 2011). "An overview of animal prion diseases". Virology Journal. 8 493. doi:10.1186/1743-422X-8-493. PMC 3228711. PMID 22044871.
- ^ Ironside JW, Ritchie DL, Barria MA (2017). "Prion diseases". Neuropathology. Handbook of Clinical Neurology. Vol. 145. pp. 393–403. doi:10.1016/B978-0-12-802395-2.00028-6. ISBN 978-0-12-802395-2. PMID 28987186.
- ^ Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ (2000). "Iatrogenic Creutzfeldt–Jakob disease at the millennium". Neurology. 55 (8): 1075–81. doi:10.1212/WNL.55.8.1075. PMID 11071481.
- ^ "Variant Creutzfeldt-Jakob disease". World Health Organization. Retrieved 2017-04-25. February 2012. Archived from the original on December 20, 2002.
- ^ "About Variant Creutzfeldt-Jakob Disease (vCJD)". CDC. 12 November 2024.
- ^ Collinge, John; Sidle, Katie C. L.; Meads, Julie; Ironside, James; Hill, Andrew F. (October 1996). "Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD". Nature. 383 (6602): 685–690. Bibcode:1996Natur.383..685C. doi:10.1038/383685a0. PMID 8878476.
- ^ Ritchie DL, Barria MA (2021). "Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?". Biomolecules. 11 (2): 207. doi:10.3390/biom11020207. PMC 7912988. PMID 33540845.
- ^ Lee KS, Caughey B (2007). "A simplified recipe for prions". Proceedings of the National Academy of Sciences USA. 104 (23): 9551–9552. Bibcode:2007PNAS..104.9551L. doi:10.1073/pnas.0703910104. PMC 1887566. PMID 17535888.
- ^ Geoghegan, James C.; Valdes, Pablo A.; Orem, Nicholas R.; Deleault, Nathan R.; Williamson, R. Anthony; Harris, Brent T.; Supattapone, Surachai (December 2007). "Selective Incorporation of Polyanionic Molecules into Hamster Prions". Journal of Biological Chemistry. 282 (50): 36341–36353. doi:10.1074/jbc.M704447200. PMC 3091164. PMID 17940287.
- ^ Shaked, GM; Meiner, Z; Avraham, I; Taraboulos, A; Gabizon, R (27 April 2001). "Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods". The Journal of Biological Chemistry. 276 (17): 14324–8. doi:10.1074/jbc.M007815200. PMID 11152454.